Intellectual Property India Publishes Patent Application for 'N-Acryloylmorpholine Derivatives As Keap1 Modulators And Uses Thereof' Filed by Vividion Therapeutics, Inc.

MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202517029970 A) filed by Vividion Therapeutics, Inc., San Diego, on March 28, for 'n-acryloylmorpholine derivatives as keap1 modulators and uses thereof.'

Inventor(s) include Weinstein, David; Green, Jason; Kikuchi, Shota; Rogness, Donald C; Alabi, Philip; Patricelli, Matthew; Roy, Nilotpal; and Lo, I-Chung.

The application for the patent was published on April 25, under issue no. 17/2025.

According to the abstract released by the Intellectual Property India: "Compounds and methods for inhibiting Nrf2 by activating KEAP1."

The patent application was internationally filed on Sept. 28, 2023, under International application No.PCT/US2023/075401.

Dis...